You can have a part of Amoneta Diagnostics via Crowdfunding operation open now !
![](http://www.firalis.com/wp-content/uploads/2018/11/01-1024x682.jpg)
Amoneta develops a biomarker based non-invasive, simple and realiable blood test for early diagnosis of Alzheimer supported by several EU funding.
As agreed by the majority of KOLs; "an efficient and simple diagnosis of Alzheimer's Disease based on innovative biomarkers is essential to come up with better treatments".